Presentation is loading. Please wait.

Presentation is loading. Please wait.

Alan Menter, MD, Chair, Alice Gottlieb, MD, PhD, Steven R

Published byScott Weaver Modified over 5 years ago

Similar presentations

Presentation on theme: "Alan Menter, MD, Chair, Alice Gottlieb, MD, PhD, Steven R"— Presentation transcript:

1 Guidelines of care for the management of psoriasis and psoriatic arthritis 
Alan Menter, MD, Chair, Alice Gottlieb, MD, PhD, Steven R. Feldman, MD, PhD, Abby S. Van Voorhees, MD, Craig L. Leonardi, MD, Kenneth B. Gordon, MD, Mark Lebwohl, MD, John Y.M. Koo, MD, Craig A. Elmets, MD, Neil J. Korman, MD, PhD, Karl R. Beutner, MD, PhD, Reva Bhushan, PhD  Journal of the American Academy of Dermatology  Volume 58, Issue 5, Pages (May 2008) DOI: /j.jaad Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Photographs of patients with psoriasis. A, Small plaque psoriasis. B, Localized thick plaque type psoriasis. C, Large plaque psoriasis. D, Inflammatory localized psoriasis. E, Erythrodermic psoriasis. F, Psoriasis and psoriatic arthritis. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

3 Fig 2 Photographs of patients with psoriasis. A, Thin plaque type psoriasis. B, Inverse type psoriasis. C, Pustular type psoriasis. D, Guttate type psoriasis. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

4 Fig 3 Photographs of patients with nail psoriasis.
Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

5 Fig 4 Decision tree. ∗Patients with nondeforming psoriatic arthritis without any radiographic changes, loss of range of motion, or interference with tasks of daily living should not automatically be treated with tumor necrosis factor (TNF) inhibitors. It would be reasonable to treat these patients with nonsteroidal anti-inflammatory agent or to consult rheumatologist for therapeutic options. †Patients with limited skin disease should not automatically be treated with systemic treatment if they do not improve, because treatment with systemic therapy may carry more risk than the disease itself. MTX, Methotrexate; PUVA; psoralen plus ultraviolet (UV)-A. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

Download ppt "Alan Menter, MD, Chair, Alice Gottlieb, MD, PhD, Steven R"

Similar presentations

Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment  Juul M.P.A.

Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment  Juul M.P.A.
Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients  Lily Chen, BA, Feng Gao, MD, PhD, MPH,

Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients  Lily Chen, BA, Feng Gao, MD, PhD, MPH,
Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 

Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 
Yul W. Yang, MD, PhD, David J. DiCaudo, MD 

Yul W. Yang, MD, PhD, David J. DiCaudo, MD 
Daniel S. Winchester, MD, Thomas L. Hocker, MD, Randall K. Roenigk, MD 

Daniel S. Winchester, MD, Thomas L. Hocker, MD, Randall K. Roenigk, MD 
OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results  Alexa B. Kimball,

OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results  Alexa B. Kimball,
Image registration of sequential transparent photographs to localize and detect new versus recurrent tumors in dermatologic and Mohs micrographic surgery 

Image registration of sequential transparent photographs to localize and detect new versus recurrent tumors in dermatologic and Mohs micrographic surgery 
Efficacy of simvastatin in plaque psoriasis: A pilot study

Efficacy of simvastatin in plaque psoriasis: A pilot study
Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 
Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis  Federica Ricceri, MD, Leonardo.

Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis  Federica Ricceri, MD, Leonardo.
Surveillance and assessment of occupational dermatitis using Rhode Island workers' compensation data 1998 to 2002  Irwin B. Horwitz, PhD, Brian P. McCall,

Surveillance and assessment of occupational dermatitis using Rhode Island workers' compensation data 1998 to 2002  Irwin B. Horwitz, PhD, Brian P. McCall,
Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J

Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J
Photo-induced Stevens-Johnson syndrome

Photo-induced Stevens-Johnson syndrome
The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study  Hsien-Yi Chiu, MD, Tsen-Fang.

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study  Hsien-Yi Chiu, MD, Tsen-Fang.
Pediatric teledermatology: Observations based on 429 consults

Pediatric teledermatology: Observations based on 429 consults
Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment  Juul M.P.A.

Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment  Juul M.P.A.
Brad A. Yentzer, MD, Ali Alikhan, BS, Hoa Teuschler, MS, Lisa L

Brad A. Yentzer, MD, Ali Alikhan, BS, Hoa Teuschler, MS, Lisa L
Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD 

Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD 
David T. Pompei, Pharm D, Kameron S. Rezzadeh, BS, Kate V

David T. Pompei, Pharm D, Kameron S. Rezzadeh, BS, Kate V
Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 

Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 

Similar presentations

Ads by Google